P158 Belimumab for the treatment of systemic lupus erythematosus in the real world: a single center study

Autor: Jorge Juan Fragío Gil, Roxana González Mazarío, Sara Moner Marín, Pablo Martínez Calabuig, Laura Salvador Maicas, Clara Molina Almela, Amalia Rueda Cid, Mireia Sanmartín Martínez, Juan José Lerma Garrido, Cristina Campos Fernández

Publikováno v: Lupus Science and Medicine, Vol 11, Iss Suppl 1 (2024)

Externí odkaz: https://doaj.org/article/06848de5cdcf4ec2b829d41f7c50b4c3

Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register

Autor: Santos Castañeda, Ricardo Blanco, Héctor Corominas, Patricia Carreira, Ivan Castellví, Eugenio De Miguel, Javier Narváez, Judit LLuch, Ivette Casafont-Solé, Jose María Pego, Lydia Abasolo, Carmen Larena, Francisco Ortiz-Sanjuán, Clara Moriano Morales, Elvira Díez Álvarez, Miguel Ángel González-Gay, Berta Magallares, Monica Ibañez Barcelo, Laura Garrido Courel, Vanesa Hernandez Hernandez, Patricia Moya Alvarado, Anne Riveros Frutos, Margarida Vasques Rocha, María Alcalde Villar, Antonio Juan Mas, Julio Sanchez, Joan Calvet, Clara Molina Almela, Amalia Rueda Cid, Cristina Campos Fernández, Carmen Riesco Bárcena, Patricia Moran Alvarez, Judit Font Urgelles, Alejandro Muñoz Jiménez, Delia Fernández-Lozano, Iñigo Hernández-Rodríguez, Marta Domínguez-Álvaro, Maite Silva-Díaz, Joaquín María Belzunegui, Eva Galíndez-Agirregoikoa, Vicente Aldaroso, Javier Loricera, Noemi Garrido-Puñal, Vanessa Andrea Navarro, Tarek Carlos Salman Monte, Trinidad Pérez Sandoval, Ismael González Fernández, Javier Mendizábal-Mateos, María Concepción Fito Manteca, Natividad del Val del Amo, Loreto Horcada Rubio, Inmaculada Paniagua Zudaire, Ricardo Gutiérrez Polo, Juliana Restrepo Vélez, Eduardo Loza Cortina, Elisa Fernández Fernández, Tomás Almorza, Leticia Léon Mateos, Luis Rodríguez Rodríguez, Pia Mercedes Lois Bermejo, Selene Labrada Arrabal, Susana Holgado Pérez, Jordi Camins, Javier Calvo Catalá, Rafael Benito Melero, Francisco Maceiras, Nair Pérez, Ceferino Barbazán, Irena Altabás, John Guzman, Paula Valentina Estrada Alarcón, Ana Milena Millán, AnaF Cruz Valenciano, Félix Cabero del Pozo, AnaBelén Rodríguez Cambrón, Cristina Macia Villa, Inmaculada Ros Vilamajó, Elide Toniolo, Ana Paula Cacheda, María Sagrario Bustabad Reyes, María García González, Alicia García Dorta, Jaime Calvo Allen, Miren Uriarte-Ecenarro, Cristina Valero Martínez, Esther F Vicente Rabaneda, Carlos García Porrúa, Carlota Laura Iñiguez Ubiaga, Noelia Álvarez Rivas, Tomás Ramón Vázquez Rodríguez, José Alberto Miranda Filloy, Amalia Sánchez-Andrade Fernández, Carlos Galisteo Lencastre Da Veiga, María Jesús García Villanueva, Marina Tortosa Cabañas, Marta Serrano Warleta, Aliuska Palomeque Vargas, Alberto Ruiz Román, Clara Aguilera Cros, JoséA Román Ivorra, Anderson Huaylla, Itziar Calvo Zorrilla, Jesús A Valero-Jaimes, Luis López Domínguez, Cesar Antonio Egues Dubuc, Lucia Silva Fernández

Publikováno v: RMD Open, Vol 10, Iss 1 (2024)

Objective This study aimed to estimate the incidence of giant cell arteritis (GCA) in Spain and to analyse its clinical manifestations, and distribution by age group, sex, geographical area and season.Methods We included all patients diagnosed with G

Externí odkaz: https://doaj.org/article/e9f8b06cb9dc42eb8922f2097ea3286a

Real-world experience with secukinumab in the entire axial spondyloarthritis spectrum

Autor: Francisca Sivera, Victoria Núñez-Monje, Cristina Campos-Fernández, Isabel Balaguer-Trull, Montserrat Robustillo-Villarino, Marta Aguilar-Zamora, Marta Garijo-Bufort, Juan Miguel López-Gómez, Carolina Peña-González, Isabel de la Morena, Diego Bedoya-Sanchís, Liliya Yankova-Komsalova, Arantxa Conesa-Mateos, Anna Martínez-Cristóbal, Francisco Javier Navarro-Blasco, José Miguel Senabre-Gallego, Juan José Alegre-Sancho

Publikováno v: Frontiers in Medicine. 10

BackgroundSecukinumab is a biologic disease-modifying antirheumatic drug (bDMARD) that has demonstrated efficacy in the treatment of axial spondyloarthritis (axSpA, i.e., ankylosing spondylitis and non-radiographic axSpA) across various clinical tria

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98ca874379b521feb44d468379473c2f

Prospective multicentre study of experience in real-world clinical practice in monitoring reported outcome measures (PROMs) of patient with a diagnosis of psoriatic and/or spondyloarthritis and initiating treatment with secukinumab

Autor: Juan José, Lerma Garrido, Antonio, Gracia Pérez, Antonio, Pérez Torres, Amalia, Rueda Cid, Clara, Molina Almela, María Dolores, Pastor Cubillo, Cristina, Campos Fernández, Isabel, Balaguer Trull, Loreto, Carmona, Javier, Calvo Catalá

Publikováno v: Reumatología Clínica (English Edition). 18:25-29

To analyse the effect of secukinumab on self-reported variables of patients diagnosed with psoriatic arthritis and/or ankylosing spondylitis in relation to their health status, pain, fatigue, sleep and quality of life.A six-month, observational, long

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a83bb25cad869f0dd9006c6f47d4aae
https://doi.org/10.1016/j.reumae.2020.07.010

Enfoque organizativo y clínico de la osteoporosis en reumatología: encuesta y consenso OP-SER-Excellence

Autor: P. Aguado, Diana Gavilan, José Rosas, M. Dolores Toledo, Cristina Campos Fernández, Teresa González, Javier de Toro, Antonio Naranjo

Publikováno v: Reumatología Clínica. 17:322-328

Resumen Introduccion Los estudios de opinion sobre la percepcion del reumatologo de la practica asistencial en osteoporosis (OP) pueden ayudar a identificar areas de mejora en la gestion de esta patologia. Objetivo Conocer y analizar el enfoque organ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::60d989672a1ad0da8c39eef854069e37
https://doi.org/10.1016/j.reuma.2019.11.002